Lenz Therapeutics
(NASDAQ) LENZ
Lenz Therapeutics Financials at a Glance
Market Cap
$359.52M
Revenue (TTM)
$17.50M
Net Income (TTM)
$58.88M
EPS (TTM)
$-2.11
P/E Ratio
-5.45
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$10.83
Volume
13,795
Open
$11.53
Price
$10.83
Volume
13,795
Open
$11.53
Previous Close
$11.49
Daily Range
$10.79 - $11.53
52-Week Range
$10.79 - $50.40
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$10.83
Volume
13,795
Open
$11.53
Previous Close
$11.49
Daily Range
$10.79 - $11.53
52-Week Range
$10.79 - $50.40
LENZ News
LENZ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lenz Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
42
CEO
Evert B. Schimmelpennink
Website
www.lenz-tx.comHeadquarters
Solana Beach, CA 92014, US
LENZ Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-4%
Net Income Margin
-3%
Return on Equity
-29%
Return on Capital
-35%
Return on Assets
-28%
Earnings Yield
-18.35%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$359.52M
Shares Outstanding
31.29M
Volume
13.79K
Short Interest
0.00%
Avg. Volume
936.59K
Financials (TTM)
Gross Profit
$58.00K
Operating Income
$58.61M
EBITDA
$49.71M
Operating Cash Flow
$59.39M
Capital Expenditure
$468.00K
Free Cash Flow
$59.86M
Cash & ST Invst.
$209.03M
Total Debt
$1.38M
Lenz Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.50M
N/A
Gross Profit
$12.38M
N/A
Gross Margin
99.00%
N/A
Market Cap
$359.52M
N/A
Market Cap/Employee
$59.92M
N/A
Employees
6
N/A
Net Income
$16.70M
-63.5%
EBITDA
$16.57M
-28.1%
Quarterly Fundamentals
Net Cash
$201.71M
-6.4%
Accounts Receivable
$0.00
N/A
Inventory
$949.00K
N/A
Long Term Debt
$461.00K
-51.6%
Short Term Debt
$0.00
-100.0%
Return on Assets
-27.95%
N/A
Return on Invested Capital
-34.93%
N/A
Free Cash Flow
$9.03M
+16.2%
Operating Cash Flow
$8.59M
+18.8%